GlassScriptPhysician profile
Sunny J Patel
NPI 1578978599
$7,081.25
in general payments reported to CMS, 2019-2025
32 companies · $765 in 2025
The $765 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,996 · 2020: $902 · 2021: $921 · 2022: $993 · 2023: $894 · 2024: $611 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,269.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,429.22 | 2019-2023 | Ortholoc 3di Crosscheck, Ortholoc 2 Lapifuse |
| Arthrosurface Incorporated | $1,210.42 | 2019 | |
| Horizon Therapeutics Plc | $688.72 | 2020-2023 | Krystexxa |
| Smith+Nephew, INC. | $321.32 | 2021-2022 | |
| Melinta Therapeutics, LLC | $312.25 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $267.36 | 2022-2025 | Nuzyra |
| Abbvie INC. | $244.09 | 2024 | |
| Convatec INC. | $240.91 | 2023-2025 | |
| Integra Lifesciences Corporation | $215.49 | 2021-2022 | |
| Organogenesis INC. | $187.09 | 2024-2025 | Affinity, Novachor, Cygnus Dual |
| Amgen INC. | $150.95 | 2024 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $150.05 | 2025 | |
| Kerecis Limited | $145.27 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ani Pharmaceuticals, INC. | $143.58 | 2025 | Purified Cortrophin Gel |
| Misonix INC | $135.46 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $126.89 | 2025 | Inceptiv, Intellis Adaptivestim |
| Cardiovascular Systems INC. | $123.80 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $118.46 | 2022 | |
| Medline Industries LP | $111.45 | 2021 | |
| Wright Medical Technology, INC. | $109.77 | 2019 | |
| Osteomed LLC | $96.38 | 2019 | |
| Medshape, INC. | $88.42 | 2020 | |
| Bioventus LLC | $86.76 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $85.49 | 2023 | Qutenza |
| Kci USA, INC. | $71.18 | 2020 | |
| Linvatec Corporation | $59.45 | 2025 | Neospan, Colink Plating System, Biobrace 23mm |
| Lifenet Health | $42.85 | 2025 | Theragenesis Wound Matrix |
| Sandoz INC. | $40.28 | 2020-2021 | |
| Orthofix Medical, INC. | $31.85 | 2023 | Physio-Stim |
| Nabriva Therapeutics, Plc | $21.01 | 2021 | |
| Sebela Pharmaceuticals INC. | $13.49 | 2020 | |
| Mayne Pharma Commercial LLC | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunny Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.